Belpointe Asset Management LLC Amarin Corp Plcuk Transaction History

Belpointe Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.19 - $2.19 $581 - $1,070	-489 Reduced 30.97%	1,090 $1,000
Q4 2022 Feb 08, 2023	BUY	$1.07 - $1.34 $1,689 - $2,115	1,579 New	1,579 $1,000
Q3 2020 Nov 13, 2020	SELL	$3.64 - $7.76 $52,743 - $112,442	-14,490 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$4.78 - $8.26 $69,262 - $119,687	14,490 New	14,490 $100,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.